Publisher Summary This chapter focuses on the new therapies for malaria. Malaria is one of
the world's most deadly diseases that threatens 40% of the world's population and infects …

Malaria was estimated to cause 800,000 deaths and 225 million cases worldwide in 2010.
Worryingly, the first-line treatment currently relies on a single drug class called artemisinins …

Malaria continues to be a major threat in the developing world, with> 1 million clinical
episodes and 3000 deaths every day. In the last century, malaria claimed between 150 and …

This minireview series highlights recent developments in malaria research. The reviews
cover diverse topics, from conventional antimalarial therapies and the strategies used to …

Development of new medicines for malaria is a challenging and important topic of applied
research because malarial parasites rapidly adapt to man-made interventions. Best studied …

Over the last 5 years, there has been an increased investment in malaria medicines, with the
emergence of a range of new fixed dose artemisinin combination therapies (FACTs). Of the …

Malaria is one of the most widespread infectious diseases of our time. About 40% of the
world's population live in countries where the disease is endemic and around 243 million …

Great progress has been made in recent years to reduce the high level of suffering caused
by malaria worldwide. Notably, the use of insecticide-treated mosquito nets for malaria …

Malaria is one of the most devastating diseases the world has ever known affecting almost
250 million people a year and resulting in over 860,000 deaths, mostly of children under the …

Natural products have made a crucial and unique contribution to human health, and this is
especially true in the case of malaria, where the natural products quinine and artemisinin …